Geographical variation in the penetrance of CDKN2A mutations for melanoma

Journal of the National Cancer Institute

Volumn 94, Issue 12, 2002, Pages 894-903

  Bishop, D Timothy ^a,j   Demenais, Florence ^b   Goldstein, Alisa M ^c   Bergman, Wilma ^d   Bishop, Julia Newton ^a   Bressac De Paillerets, Brigitte ^e   Chompret, Agnès ^e   Ghiorzo, Paola ^f   Gruis, Nelleke ^d   Hansson, Johan ^g   Harland, Mark ^a   Hayward, Nicholas ^h   Holland, Elizabeth A ⁱ   Mann, Graham J ⁱ   Mantelli, Michela ^f   Nancarrow, Derek ^h   Platz, Anton ^g   Tucker, Margaret A ^c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSERM   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f UNIVERSITY OF GENOA   (Italy)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h Queensland Cancer Fund Research Unit   (Australia)

ⁱ WESTMEAD HOSPITAL   (Australia)

^j ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; EUROPE; FAMILY; FEMALE; GENDER; GENE MUTATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GERM LINE; HETEROZYGOTE; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PENETRANCE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0037134702     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.12.894     Document Type: Article

References (59)

1. Clinical and genetic studies in-six Dutch kindred with the Dysplastic Naevus Syndrome
2. Origin of familial malignant melanoma from heritable melanocytic lesions
3. Familial atypical multiple mole-melanoma (FAMMM) syndrome: Segregation analysis
4. Familial Melanoma
5. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas
6. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma
7. Homozygous deletions within human chromosome band 9p21 in melanoma
8. Confirmation of chromosome 9p linkage in familial melanoma
9. Chromosomal evolution in the progression and metastasis of human malignant melanoma
10. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: Implications for 9p tumor-suppressor gene(s)
11. Germline p16 mutations in familial melanoma
12. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
13. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
14. Inhibition of ras-induced proliferation and cellular transformation by p16INK4
15. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
16. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
17. Counselling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium
18. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
19. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations
20. CDKN2 mutations in melanoma
21. The current situation with regard to human melanoma and genetic inferences
22. INK4a binding domain of CDK4 in familial melanoma
23. The CDKN2A (p16) gene and human cancer
24. Cutaneous Malignant Melanoma
25. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma
26. Malignant melanoma in England: Risks associated with naevi, freckles, social class, hair color, and sunburn
27. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors
28. Cancer incidence in five continents. Age-standardized incidence rates, four-digit rubrics, and age-standardized and cumulative incidence rates, three-digit rubrics
29. Mutations of the CDKN2/p161INK4 gene in Australian melanoma kindreds
30. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
31. Germline CDKN2A mutations in childhood melanoma
32. CDKN2A variants in a population-based sample of Queensland families with melanoma
33. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
34. Mutation screening of the CDKN2A promoter in melanoma families
35. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds
36. Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations
37. Mutation testing in melanoma families INK4A, CDK4 and INK4D
38. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
39. Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
40. The Dutch FAMMM family material: Clinical and genetic data
41. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
42. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
43. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
44. Melanoma development in relation to non-functional p16/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindreds
45. INK4a/CDKN2A: Correlation with protein structure information
46. Regressive logistic models for familial disease and other binary traits
47. A time-dependent logistic hazard function for modeling variable age of onset in analysis of familial diseases
48. Combined linkage and segregation analysis using regressive models
49. Lods, wrods, and mods: The interpretation of lod scores calculated under different models
50. REGRESS: A computer program including the regressive approach into the LINKAGE programs
51. Recommendations for a nomenclature system for human gene mutations
52. Novel germline p16 mutation in familial malignant melanoma in southern Sweden
53. Sporadic multiple primary melanoma a cases: CDKN2A germline mutations with a founder effect
54. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families
55. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93
56. Malignant melanoma incidence in Connecticut (US): Time trends and age-period-cohort modeling by anatomic site
57. Recent cohort trends in malignant melanoma by anatomic site in the United States